Ophelia

Ophelia is dedicated to combating opioid addiction by providing accessible, at-home treatment options. The platform offers online consultations with physicians, prescriptions for withdrawal medications, and ongoing support for sustained recovery. Their approach leverages a protocol that demonstrates significantly higher effectiveness compared to traditional rehabilitation centers, many of which lack adequate medical professionals.

With over three million Americans struggling with opioid addiction, a staggering 80% are unable to access the help they need due to various obstacles such as employment, family responsibilities, and privacy considerations. Medication-Assisted Treatment (MAT), a scientifically validated method involving medication and therapy, has been shown to increase survival rates by 600%. Despite its proven benefits, access to MAT remains limited due to the requirement for doctors to possess a special waiver, held by less than 5% of physicians. This scarcity forces many individuals to seek alternatives from illicit sources, leading to tragic consequences, with an opioid overdose occurring every 11 minutes in the United States.

Ophelia aims to revolutionize opioid addiction treatment by replacing traditional rehab with convenient telemedicine services, grounded in scientific evidence and a patient-centric approach. The U.S. opioid treatment market represents a $15 billion opportunity, with a substantial portion covered by insurance. Ophelia currently serves approximately 400 patients and seeks to expand its reach to address the extensive waiting list.

Driven by personal experience, founder Zack established Ophelia after the loss of his girlfriend to an opioid overdose. The company is currently raising capital to expand its services, reduce patient wait times, and ultimately save lives while generating returns for investors.